- Global Pharma News & Resources

Global Insomnia Pipeline Review, H2 2018 -

The "Insomnia - Pipeline Review, H2 2018" drug pipelines has been added to's offering.

Insomnia - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Insomnia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes; the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 9, 6, 8, 5 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Insomnia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Insomnia - Overview
  3. Insomnia - Therapeutics Development
  4. Insomnia - Therapeutics Assessment
  5. Insomnia - Companies Involved in Therapeutics Development
  6. Insomnia - Drug Profiles
  7. Insomnia - Dormant Projects
  8. Insomnia - Discontinued Products
  9. Insomnia - Product Development Milestones
  10. Appendix

Companies Featured

  • Alexza Pharmaceuticals Inc
  • Eisai Co Ltd
  • Evotec AG
  • Grupo Ferrer Internacional SA
  • Heptares Therapeutics Ltd
  • Icure Pharmaceutical Inc
  • Idorsia Pharmaceutical Ltd
  • Intra-Cellular Therapies Inc
  • Johnson & Johnson
  • Leading BioSciences Inc
  • Merck & Co Inc
  • Neurim Pharmaceuticals Ltd
  • Purdue Pharma LP
  • Reviva Pharmaceuticals Inc
  • Sage Therapeutics Inc
  • Shionogi & Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Yangtze River Pharmaceutical Group

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 19-Oct-2018